nejm.org
Retatrutide, a Triple Hormone Receptor Agonist, for Treatment of Obesity | NEJM
Retatrutide is a triple-receptor agonist of glucose-dependent insulinotropic polypeptide,
glucagon-like peptide-1, and glucagon receptors. In this phase 3, randomized, double-blind
trial, we assign...